Real-time enrollment status for this metastatic prostate cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:43 AM UTC
| NCT Number | NCT05413421 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 275 participants |
| Active Locations | 20 sites in the US |
| Sponsor | ORIC Pharmaceuticals |
| Last Updated on CT.gov | July 9, 2026 (4 days ago) |
As of July 13, 2026: Clinical trial NCT05413421 is currently recruiting participants. This clinical trial study for metastatic prostate cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by ORIC Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05413421 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05413421 was last updated 4 days ago (July 9, 2026). HelloStudys verifies this status automatically.